Where we've been, who we've met, and what the regulated markets are actually asking for. Recaps from Arab Health and WHX Dubai sit alongside working briefs on unlicensed medicines, cold-chain logistics and the paperwork that actually clears customs.
Arab Health 2024, Arab Health 2025 and WHX Dubai 2026, plus the RBMI campus dialogue on pharmacy careers. Four events, with booth imagery, the themes we led with, and what GCC and African buyers were asking about.
See all events →MHRA Specials vs parallel import. GCC Central Registration. QP certification for Germany. Named-patient imports into the UK. African oncology tenders. CTD Module 3 section by section. GDP audits, cold-chain lanes and WHO-GMP documentation. Field-grade writing, not content-marketing fluff.
Read the blog →Three recent briefings from the desk. For event recaps, see the events lane above.
Pre-qualification, the bid pack, the Saudi Pricing Committee, bilingual artwork, and the six places first-time Indian bidders trip.
Two UK routes that live on opposite sides of a single line. Specials under Regulation 167, parallel import under a PLPI, when procurement uses which, and where the paperwork diverges.
KEMSA, NMS, MSD, CMS, EPSS and the FMoH each structure their oncology RFQs differently. What the bid document is actually asking for, and the four lines that separate a winning response.
Send the molecule, the volume and the destination. A named person replies inside one working day with price, timeline and regulatory status.
Start an enquiry →
